Side effects of systemic retinoid therapy in patients with severe psoriasis
Year: 2013, volume 9 Issue: №3 Pages: 549-552
Heading: Dermatovenerology Article type: Original article
Authors: Slesarenko N.A., Bakulev A.L., Shabogina A.A., Platonova A.N., Utz S.R., Markina M.V., Shtoda U.M.
Organization: Saratov State Medical University
Heading: Dermatovenerology Article type: Original article
Authors: Slesarenko N.A., Bakulev A.L., Shabogina A.A., Platonova A.N., Utz S.R., Markina M.V., Shtoda U.M.
Organization: Saratov State Medical University
Summary:
The aim: To determine the nature and frequency of side effects observed on acitretin therapy of patients with severe forms of psoriasis. Materials and methods. The study included 20 patients with generalized pustular psoriasis. Due to the inefficiency of the ongoing standard therapy, in addition to the plan of treatment, all patients were included systemic retinoid — acitretin (neotigazon) at a dose of 0,3-0,5 mg/kg per day. I control group consisted of patients with psoriasis receiving standard therapy without the use of systemic retinoids. II control group consisted of patients taking acitretin about keratosis. Results. In 18 patients of the main group noted the development of side effects, such as xerosis and nail fragility. In 14 patients of the main group and 3 patients of the II control group the results of urinalysis tests and Nechiporenko sample were detected by elevated levels of red blood cells and the development of hematuria. Conclusion. The study found that 17 patients had development of hematuria, which can be considered regarded as a side effect of acitretin therapy.
Bibliography:
1. John Berth-Jones. Psoriasis // Medicine. 2013. Vol. 46, № 6. P. 334-340;
2. Kubanova A.A., Katunina O.R. Immunomorfologija i mor-fogenez ochagov porazhennoj kozhi pri psoriaze // Vestn. derma-tol. 2010. №1. S. 70-79;
3. Immunopathogenesis of psoriasis / R. Sabat, S. Philipp [et al.] // Experimental Dermatology. 2007. Vol. 16, №10. R. 779-798;
4. Hamaganova I.V., Shekrota A.G., Nikiforova G.D., Kolibri-na A.M. Primenenie gastrointestinal»nyh preparatov v komplek-snoj terapii psoriaza // Ros. med. zhurn. 2005. № 5. S. 240;
5. Gudzhonson Dzh., Jelder Dzh. Psoriaz // Dermatologija Ficpatrika v klinicheskoj praktike: v 3 t. M., 2012. T. 1. S. 180-207;
6. Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation / Yoon-Soo Cindy Bae, Abby S. Van Voorhess, Sylvia Hsu [et al.] // J.Am. Acad. Dermatol. 2012. № 67. P. 459-477;
7. Yogeeta Agrawal, Kailash С Petkar, Krutika K. Sawant. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis // International Journal of Pharmaceutics. 2010. № 401. R. 93-102;
8. Bahner J. D., Cao L.Y., Korman N. J. Biologies in the management of psoriasis // Clin. Cosmet. Investig. Dermatol. 2009. №2. P. 111-128;
9. Valguest A., Kujenzli S. Retinoidy // Dermatologija Ficpatrika v klinicheskoj praktike: v 3 t. M., 2013. T. 3. S. 2379-2384.
10. Kang S., Vurges Dzh. Mestnye retinoidy. // Dermatologija Ficpatrika v klinicheskoj praktike: v 3 t. M., 2013. T. 3. S. 2296-2303;
11. Ann L. Marqueling, Kelly M. Cordoro. Systemic Treatments for Severe Pediatric Psoriasis // Dermatol. Clin. 2013. № 3. R. 267-288;
12. Kai Li, April W. Armstrong. A Review of Health Outcomes in Patients with Psoriasis // Dermatol. Clin. 2012. № 30. P. 61-72;
13. Zsuzsanna Bata-Csorgo, Marta Szell. The psoriatic keratinocytes// Expert Rev. Dermatol. 2012. Vol. 7, № 5. P. 473-481;
14. European S3 — Guidelines on the systemic treatment of psoriasis vulgaris / D. Pathirana [et al.] //JEADV 2009. Vol. 23 (suppl. 2). P. 5-70.
| Attachment | Size |
|---|---|
| 2013-03_1-549-552.pdf | 262.42 KB |
Русский
English